BackCoeptis Therapeutics Holdings- Warrants (31/10/2025) Overview

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Total Liabilities

Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s total liabilities is $390K.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$390530.00
15.54% YoYΔ $52531.00 vs prior year quarter

Peer average

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Total Liabilities History

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) vs. peers: Total Liabilities Comparison

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) (COEPW) FAQ

As of the most recent data (March 2026), COEPW shows a total liabilities of $390K. That compares with $340K in the prior-year period — up 15.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, COEPW's total liabilities is now $390K (was $340K) — a 15.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Coeptis Therapeutics Holdings- Warrants (31/10/2025) is outperforming or lagging.

Tracking COEPW's total liabilities over time shows whether Coeptis Therapeutics Holdings- Warrants (31/10/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $390K That compares with $340K in the prior-year period — up 15.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $390K) with ownership activity and broader fundamentals.